Related Experiment Video
Updated: Nov 30, 2025

Detecting Migration and Infiltration of Neutrophils in Mice
Published on: February 6, 2020
A neutrophil signature is strongly associated with increased cardiovascular risk in gout
Daisy Vedder1,2, Martijn Gerritsen1, Michael T Nurmohamed1,2,3
1Amsterdam Rheumatology and Immunology Center Reade, Amsterdam, The Netherlands.
Insights
Neutrophil activation markers are elevated in gout patients and linked to cardiovascular disease risk factors. A "neutrophil activation signature" significantly increases the 10-year risk of cardiovascular mortality in gout patients.
Area of Science:
- Rheumatology
- Cardiology
- Immunology
Background:
- Gout is associated with an increased risk of cardiovascular disease.
- Neutrophil activation and neutrophil extracellular traps (NETs) are implicated in inflammatory processes and atherogenesis.
Purpose of the Study:
- To investigate the association between neutrophil activation and cardiovascular risk in gout patients.
- To determine if neutrophil activation markers correlate with cardiovascular risk factors and mortality risk.
Main Methods:
- Analysis of neutrophil activation markers (calprotectin, peroxidase activity) and NETs in 75 gout patients and healthy controls.
- Correlation of neutrophil activation markers with clinical cardiovascular risk factors (BMI, blood pressure, lipids) and 10-year cardiovascular mortality risk (EU-SCORE).
Main Results:
- Gout patients showed elevated levels of neutrophil activation markers (peroxidase, calprotectin) compared to controls.
- Peroxidase activity correlated with waist:hip ratio, cholesterol ratio, triglycerides, and 10-year cardiovascular mortality risk.
- A 'neutrophil activation signature' (high peroxidase and calprotectin) was strongly associated with elevated cardiovascular risk and mortality risk.
Conclusions:
- Elevated neutrophil activation markers are present in gout patients and associated with cardiovascular risk factors like hyperlipidemia, hypertension, and diabetes.
- The 'neutrophil activation signature' is a significant predictor of increased 10-year cardiovascular mortality risk in gout patients.
- Further research is needed to elucidate the interplay between gout, cardiovascular risk factors, and neutrophil activation.
Objective:
To investigate the association between neutrophil activation and cardiovascular risk in gout patients. We hypothesize that neutrophil activation mediates inflammation and therefore takes part in atherogenesis in gout patients.
Method:
Patient data were collected from 75 consecutive gout patients participating in the Reade gout cohort Amsterdam. Levels of neutrophil extracellular traps (NETs) and neutrophil activation (calprotectin and peroxidase activity) were analysed by ELISA and fluorimetry in plasma and compared with healthy controls. Markers of neutrophil activation were related to clinical markers of cardiovascular risk, including BMI, smoking, blood pressure, lipid profile and 10 year risk of cardiovascular mortality (EU-SCORE).
Results:
Increased levels of NETs were found in gout patients, although increased levels were not associated with cardiovascular risk. However, markers of neutrophil activation, including peroxidase activity correlated with waist:hip ratio (β = 0.33, P < 0.001), cholesterol ratio (β = 0.46, P < 0.005) and triglycerides (β = 0.60, P < 0.001) as well as the 10 year risk of cardiovascular mortality (β = 0.44, P = 0.001). Calprotectin levels were elevated in hypertension (P = 0.005) and diabetes (P = 0.02). Finally, gout patients with high levels of both peroxidase and calprotectin ('neutrophil activation signature') had a markedly elevated cardiovascular risk score (P = 0.001), with 68% of the patients having high cardiovascular risk (odds ratio 2.9, P = 0.03).
Conclusion:
We demonstrated elevated levels of neutrophil activation markers, MPO and calprotectin in gout patients as compared with healthy controls. Of note, neutrophil activation markers were associated with several risk factors for cardiovascular disease, including hyperlipidaemia, hypertension and diabetes. Finally, the presence of a neutrophil activation signature was strongly associated with an increased 10 year risk of cardiovascular mortality. Further studies are needed to determine whether gout-specific factors and/or cardiovascular risk factors contribute to the elevated neutrophil activation observed in these patients.
More Related Videos
06:48The MUB40 Peptide for Use in Detecting Neutrophil-Mediated Inflammation Events
Published on: January 7, 2019
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome I : Introduction
Inflammation
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...